These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4330998)

  • 1. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH; Buescher EL; Bancroft WH; Russell PK
    J Infect Dis; 1971 Aug; 124(2):155-60. PubMed ID: 4330998
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.
    Top FH; Grossman RA; Bartelloni PJ; Segal HE; Dudding BA; Russell PK; Buescher EL
    J Infect Dis; 1971 Aug; 124(2):148-54. PubMed ID: 4330997
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types.
    Gooch WM; Mogabgab WJ
    Arch Environ Health; 1972 Dec; 25(6):388-94. PubMed ID: 4343867
    [No Abstract]   [Full Text] [Related]  

  • 4. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
    Top FH; Dudding BA; Russell PK; Buescher EL
    Am J Epidemiol; 1971 Aug; 94(2):142-6. PubMed ID: 4327997
    [No Abstract]   [Full Text] [Related]  

  • 5. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits.
    Pierce WE; Peckinpaugh RO; Frazier WE; Griffin JP; Greenberg BH; Jackson GG
    Antimicrob Agents Chemother (Bethesda); 1965; 5():55-8. PubMed ID: 4286921
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines.
    Chaloner-Larsson G; Contreras G; Furesz J; Boucher DW; Krepps D; Humphreys GR; Mohanna SM
    Can J Public Health; 1986; 77(5):367-70. PubMed ID: 3024797
    [No Abstract]   [Full Text] [Related]  

  • 7. Concurrent administration of live adenovirus, type 4 and live Poliovirus, type 1 vaccines.
    Chin J; Lennette EH; Schieble JH; Magoffin RL
    Am J Epidemiol; 1968 May; 87(3):633-42. PubMed ID: 5654951
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971.
    Dudding BA; Top FH; Winter PE; Buescher EL; Lamson TH; Leibovitz A
    Am J Epidemiol; 1973 Mar; 97(3):187-98. PubMed ID: 4348245
    [No Abstract]   [Full Text] [Related]  

  • 9. Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits.
    Pierce WE; Rosenbaum MJ; Edwards EA; Peckinpaugh RO; Jackson GG
    Am J Epidemiol; 1968 Jan; 87(1):237-46. PubMed ID: 4295428
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent experiences with live adenovirus vaccines in navy recruits.
    Rosenbaum MJ; Edwards EA; Hoeffler DF CAPT
    Mil Med; 1975 Apr; 140(4):251-7. PubMed ID: 167324
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenovirus vaccines in military recruit populations: a cost-benefit analysis.
    Collis PB; Dudding BA; Winter PE; Russell PK; Buescher EL
    J Infect Dis; 1973 Dec; 128(6):745-52. PubMed ID: 4358121
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenovirus vaccines in the U.S. military.
    Gaydos CA; Gaydos JC
    Mil Med; 1995 Jun; 160(6):300-4. PubMed ID: 7659229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection.
    Gutekunst RR; White RJ; Edmondson WP; Chanock RM
    Am J Epidemiol; 1967 Sep; 86(2):341-9. PubMed ID: 4293744
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J; Abarbanel MF; Oei KG
    J Hyg (Lond); 1968 Dec; 66(4):499-511. PubMed ID: 4303951
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of canine adenovirus type 2 vaccine to control kennel cough syndrome.
    Powell KW
    Vet Med Small Anim Clin; 1979 Jun; 74(6):801-4. PubMed ID: 223268
    [No Abstract]   [Full Text] [Related]  

  • 16. An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines.
    Dudding BA; Top FH; Scott RM; Russell PK; Buescher EL
    Am J Epidemiol; 1972 Feb; 95(2):140-7. PubMed ID: 4334127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined immunization against influenza and other viral respiratory infections].
    Selivanov AA; Boldasov VK; Kovaleva TP; Shaposhnikova RP; Morozenko MA
    Vestn Akad Med Nauk SSSR; 1970; 25(8):33-7. PubMed ID: 4322340
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience with vaccines--general comments.
    Buescher EL
    Natl Cancer Inst Monogr; 1968 Dec; 29():527-9. PubMed ID: 4305441
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral adenoviral-based vaccines: historical perspective and future opportunity.
    Tucker SN; Tingley DW; Scallan CD
    Expert Rev Vaccines; 2008 Feb; 7(1):25-31. PubMed ID: 18251691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J; Abarbanel MF; Oei KG
    Antonie Van Leeuwenhoek; 1969; 35(2):239. PubMed ID: 4316421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.